Topp L - Search Results

1

A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.

Topp L, Day CA, Wand H, Deacon RM, van Beek I, Haber PS, Shanahan M, Rodgers C, Maher L; Hepatitis Acceptability and Vaccine Incentives Trial (HAVIT) Study Group. Topp L, et al. Prev Med. 2013 Oct;57(4):297-303. doi: 10.1016/j.ypmed.2013.04.013. Epub 2013 Apr 29. Prev Med. 2013. PMID: 23639625 Clinical Trial.

2

Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia.

Hando J, Topp L, Hall W. Hando J, et al. Among authors: topp l. Drug Alcohol Depend. 1997 Jun 6;46(1-2):105-13. doi: 10.1016/s0376-8716(97)00051-3. Drug Alcohol Depend. 1997. PMID: 9246558

3

Decreased heroin availability in Sydney in early 2001.

Day C, Topp L, Rouen D, Darke S, Hall W, Dolan K. Day C, et al. Among authors: topp l. Addiction. 2003 Jan;98(1):93-5. doi: 10.1046/j.1360-0443.2003.00266.x. Addiction. 2003. PMID: 12492759

4

Contemplating drug monitoring systems in the light of Australia's "heroin shortage".

Topp L, Degenhardt L, Day C, Collins L. Topp L, et al. Drug Alcohol Rev. 2003 Mar;22(1):3-6. doi: 10.1080/0959523021000059767. Drug Alcohol Rev. 2003. PMID: 12745352 No abstract available.

5

Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia.

Topp L, Day C, Degenhardt L. Topp L, et al. Drug Alcohol Depend. 2003 Jun 5;70(3):275-86. doi: 10.1016/s0376-8716(03)00013-9. Drug Alcohol Depend. 2003. PMID: 12757965

6

Safety in drug and alcohol research.

Day C, Topp L. Day C, et al. Among authors: topp l. Addiction. 2003 Dec;98(12):1641-3. doi: 10.1111/j.1360-0443.2003.00486.x. Addiction. 2003. PMID: 14651490 No abstract available.

7

Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs.

Topp L, Iversen J, Conroy A, Salmon AM, Maher L; Collaboration of Australian NSPs. Topp L, et al. Aust N Z J Public Health. 2008 Feb;32(1):34-7. doi: 10.1111/j.1753-6405.2008.00163.x. Aust N Z J Public Health. 2008. PMID: 18290911 Free article.

8

Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey.

Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L; Collaboration of Australian Needle Syringe Programs. Topp L, et al. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):632-8. doi: 10.1097/qai.0b013e31816a1d68. J Acquir Immune Defic Syndr. 2008. PMID: 18491422

9

Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.

Day CA, Topp L, Iversen J, Maher L; Collaboration of Australian NSPs. Day CA, et al. Among authors: topp l. Drug Alcohol Rev. 2008 Sep;27(5):559-61. doi: 10.1080/09595230801956132. Drug Alcohol Rev. 2008. PMID: 18608447 No abstract available.

10

Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.

Dwyer R, Topp L, Maher L, Power R, Hellard M, Walsh N, Jauncey M, Conroy A, Lewis J, Aitken C. Dwyer R, et al. Among authors: topp l. Drug Alcohol Depend. 2009 Feb 1;100(1-2):9-16. doi: 10.1016/j.drugalcdep.2008.08.016. Epub 2008 Nov 14. Drug Alcohol Depend. 2009. PMID: 19013725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters